The roles of the classical and alternative nuclear factor-κB pathways: Potential implications for autoimmunity and rheumatoid arthritis

Arthritis Research and Therapy

Volumn 10, Issue 4, 2008, Pages

  Brown, Keith D ^a   Claudio, Estefania ^a   Siebenlist, Ulrich ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HETERODIMER; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 17; INTERLEUKIN 6; INTERLEUKIN 8; LIGAND; PROTEIN P100; PROTEIN P50; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE;

APOPTOSIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; CELL ADHESION; CELL CYCLE PROGRESSION; CELL MATURATION; CELL SURVIVAL; HELPER CELL; HUMAN; IMMUNE SYSTEM; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE PROLIFERATION; NONHUMAN; OSTEOBLAST; OSTEOLYSIS; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SYNOVIOCYTE; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; PATHOPHYSIOLOGY; PHYSIOLOGY;

ARTHRITIS, RHEUMATOID; AUTOIMMUNITY; CYTOKINES; HUMANS; INTERLEUKIN-17; NF-KAPPA B; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 59449108567     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2457     Document Type: Review

References (133)

1. Karin M Ben-Neriah Y Phosphorylation meets ubiquitination: The control of NF-kappa B activity Annu Rev Immunol 2000, 18:621-663. 10.1146/ annurev.immunol.18.1.621 10837071
2. Li Q Verma IM NF-kappa B regulation in the immune system Nat Rev Immunol 2002, 2:725-734. 10.1038/nri910 12360211
3. Brown K Claudio E Siebenlist U New developments in NF-kappa B Contemporary Targeted Therapies in Rheumatology London: Informa Smolen JS, Lipsky PE 2007, 285-296.
4. Hayden MS Ghosh S Signaling to NF-kappaB Genes Dev 2004, 18:2195-2224. 10.1101/gad.1228704 15371334
5. Bonizzi G Karin M The two NF-kappaB activation pathways and their role in innate and adaptive immunity Trends Immunol 2004, 25:280-288. 10.1016/ j.it.2004.03.008 15145317
6. Senftleben U Cao Y Xiao G Greten FR Krahn G Bonizzi G Chen Y Hu Y Fong A Sun SC Karin M Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway Science 2001, 293:1495-1499. 10.1126/science.1062677 11520989
7. Dejardin E Droin NM Delhase M Haas E Cao Y Makris C Li ZW Karin M Ware CF Green DR The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways Immunity 2002, 17:525-535. 10.1016/S1074-7613(02)00423-5 12387745
8. Claudio E Brown K Park S Wang H Siebenlist U BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells Nat Immunol 2002, 3:958-965. 10.1038/ni842 12352969
9. Bonizzi G Bebien M Otero DC Johnson-Vroom KE Cao Y Vu D Jegga AG Aronow BJ Ghosh G Rickert RC Karin M Activation of IKKalpha target genes depends on recognition of specific kappaB binding sites by RelB:p52 dimers Embo J 2004, 23:4202-4210. 524385 15470505 10.1038/ sj.emboj.7600391
10. Cao Y Bonizzi G Seagroves TN Greten FR Johnson R Schmidt EV Karin M IKKalpha provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development Cell 2001, 107:763-775. 10.1016/S0092-8674(01)00599-2 11747812
11. Novack DV Yin L Hagen-Stapleton A Schreiber RD Goeddel DV Ross FP Teitelbaum SL The IkappaB function of NF-kappaB2 p100 controls stimulated osteoclastogenesis J Exp Med 2003, 198:771-781. 2194184 12939342 10.1084/jem.20030116
12. Silverstein AM Autoimmunity versus horror autotoxicus: The struggle for recognition Nat Immunol 2001, 2:279-281. 10.1038/86280 11276193
13. Stefanova I Dorfman JR Germain RN Self-recognition promotes the foreign antigen sensitivity of naive T lymphocytes Nature 2002, 420:429-434. 10.1038/nature01146 12459785
14. Dale E Davis M Faustman DL A role for transcription factor NF-kappa B in autoimmunity: Possible interactions of genes, sex, and the immune response Adv Physiol Educ 2006, 30:152-158. 10.1152/advan.00065.2006 17108242
15. Lipsky PE Systemic lupus erythematosus: An autoimmune disease of B cell hyperactivity Nat Immunol 2001, 2:764-766. 10.1038/ni0901-764 11526379
16. Anolik J Sanz I B cells in human and murine systemic lupus erythematosus Curr Opin Rheumatol 2004, 16:505-512. 10.1097/01.bor.0000133660.52599.f6 15314486
17. Goodnow CC Sprent J Fazekas de St Groth Vinuesa CG Cellular and genetic mechanisms of self tolerance and autoimmunity Nature 2005, 435:590-597. 10.1038/nature03724 15931211
18. Schulze-Koops H Kalden JR T cells-overview-update Contemporary Targeted Therapies in Rheumatology London: Informa Smolen JS, Lipsky PE 2007, 1-6.
19. Nutku E Pugh-Bernard AE Gauld S Merrell K Cambier JC B-cell antigen receptor signaling and autoimmunity Contemporary Targeted Therapies in Rheumatology London: Informa Smolen JS, Lipsky PE 2007, 31-44.
20. Lutzky V Thomas R Dendritic cells Contemporary Targeted Therapies in Rheumatology UK: Informa Smolen JS, Lipsky PE 2007, 63-78.
21. Siebenlist U Brown K Claudio E Control of lymphocyte development by nuclear factor-kappaB Nat Rev Immunol 2005, 5:435-445. 10.1038/nri1629 15905862
22. Claudio E Brown K Siebenlist U NF-kappaB guides the survival and differentiation of developing lymphocytes Cell Death Differ 2006, 13:697-701. 10.1038/sj.cdd.4401894 16528380
23. Verkoczy L Ait-Azzouzene D Skog P Martensson A Lang J Duong B Nemazee D A role for nuclear factor kappa B/rel transcription factors in the regulation of the recombinase activator genes Immunity 2005, 22:519-531. 10.1016/j.immuni.2005.03.006 15845455
24. Wessells J Baer M Young HA Claudio E Brown K Siebenlist U Johnson PF BCL-3 and NF-kappaB p50 attenuate lipopolysac-charide-induced inflammatory responses in macrophages J Biol Chem 2004, 279:49995-50003. 10.1074/jbc.M404246200 15465827
25. Driessler F Venstrom K Sabat R Asadullah K Schottelius AJ Molecular mechanisms of interleukin-10-mediated inhibition of NF-kappaB activity: a role for p50 Clin Exp Immunol 2004, 135:64-73. 1808913 14678266 10.1111/j.1365-2249.2004.02342.x
26. Thomas MD Kremer CS Ravichandran KS Rajewsky K Bender TP c-Myb is critical for B cell development and maintenance of follicular B cells Immunity 2005, 23:275-286. 10.1016/j.immuni.2005.08.005 16169500
27. Milne CD Fleming HE Zhang Y Paige CJ Mechanisms of selection mediated by interleukin-7, the preBCR, and hemokinin-1 during B-cell development Immunol Rev 2004, 197:75-88. 10.1111/j.0105-2896.2004.0103.x 14962188
28. Xie P Stunz LL Larison KD Yang B Bishop GA Tumor necrosis factor receptor-associated factor 3 is a critical regulator of B cell homeostasis in secondary lymphoid organs Immunity 2007, 27:253-267. 2084086 17723217 10.1016/j.immuni.2007.07.012
29. Hettmann T DiDonato J Karin M Leiden JM An essential role for nuclear factor kappaB in promoting double positive thymocyte apoptosis J Exp Med 1999, 189:145-158. 1887697 9874571 10.1084/jem.189.1.145
30. Ren H Schmalstieg A van Oers NS Gaynor RB I-kappa B kinases alpha and beta have distinct roles in regulating murine T cell function J Immunol 2002, 168:3721-3731. 11937522
31. Mora AL Stanley S Armistead W Chan AC Boothby M Inefficient ZAP-70 phosphorylation and decreased thymic selection in vivo result from inhibition of NF-kappaB/Rel J Immunol 2001, 167:5628-5635. 11698434
32. Fiorini E Schmitz I Marissen WE Osborn SL Touma M Sasada T Reche PA Tibaldi EV Hussey RE Kruisbeek AM Reinherz EL Clayton LK Peptide-induced negative selection of thymocytes activates transcription of an NF-kappa B inhibitor Mol Cell 2002, 9:637-648. 10.1016/S1097-2765(02)00469-0 11931770
33. Sivakumar V Hammond KJ Howells N Pfeffer K Weih F Differential requirement for Rel/nuclear factor kappa B family members in natural killer T cell development J Exp Med 2003, 197:1613-1621. 2193952 12810684 10.1084/jem.20022234
34. Schmidt-Supprian M Courtois G Tian J Coyle AJ Israel A Rajewsky K Pasparakis M Mature T cells depend on signaling through the IKK complex Immunity 2003, 19:377-389. 10.1016/S1074-7613(03)00237-1 14499113
35. Schmidt-Supprian M Tian J Grant EP Pasparakis M Maehr R Ovaa H Ploegh HL Coyle AJ Rajewsky K Differential dependence of CD4+CD25+ regulatory and natural killer-like T cells on signals leading to NF-kappaB activation Proc Natl Acad Sci USA 2004, 101:4566-4571. 384787 15070758 10.1073/ pnas.0400885101
36. Zheng Y Vig M Lyons J Van Parijs L Beg AA Combined deficiency of p50 and cRel in CD4+ T cells reveals an essential requirement for nuclear factor kappaB in regulating mature T cell survival and in vivo function J Exp Med 2003, 197:861-874. 2193891 12668645 10.1084/jem.20021610
37. van Santen HM Benoist C Mathis D Number of T reg cells that differentiate does not increase upon encounter of agonist ligand on thymic epithelial cells J Exp Med 2004, 200:1221-1230. 2211925 15534371 10.1084/jem.20041022
38. Burkly L Hession C Ogata L Reilly C Marconi LA Olson D Tizard R Cate R Lo D Expression of relB is required for the development of thymic medulla and dendritic cells Nature 1995, 373:531-536. 10.1038/373531a0 7845467
39. Kobayashi T Walsh PT Walsh MC Speirs KM Chiffoleau E King CG Hancock WW Caamano JH Hunter CA Scott P Turka LA Choi Y TRAF6 is a critical factor for dendritic cell maturation and development Immunity 2003, 19:353-363. 10.1016/S1074-7613(03)00230-9 14499111
40. Kajiura F Sun S Nomura T Izumi K Ueno T Bando Y Kuroda N Han H Li Y Matsushima A Takahama Y Sakaguchi S Mitani T Matsumoto M NF-kappa B-inducing kinase establishes self-tolerance in a thymic stroma-dependent manner J Immunol 2004, 172:2067-2075. 14764671
41. Akiyama T Maeda S Yamane S Ogino K Kasai M Kajiura F Matsumoto M Inoue J Dependence of self-tolerance on TRAF6-directed development of thymic stroma Science 2005, 308:248-251. 10.1126/science.1105677 15705807
42. Zhang B Wang Z Ding J Peterson P Gunning WT Ding HF NF-kappaB2 is required for the control of autoimmunity by regulating the development of medullary thymic epithelial cells J Biol Chem 2006, 281:38617-38624. 1847381 17046818 10.1074/jbc.M606705200
43. Zhang X Wang H Claudio E Brown K Siebenlist U A role for the IkappaB family member Bcl-3 in the control of central immunologic tolerance Immunity 2007, 27:438-452. 10.1016/j.immuni.2007.07.017 17869136
44. Thomas R The TRAF6-NF-kappa B signaling pathway in autoimmunity: Not just inflammation Arthritis Res 2005, 7:170-173. 10.1186/ar1784 15987501 1175050
45. Derbinski J Kyewski B Linking signalling pathways, thymic stroma integrity and autoimmunity Trends Immunol 2005, 26:503-506. 10.1016/ j.it.2005.07.006 16039157
46. Pahl HL Activators and target genes of Rel/NF-kappa B transcription factors Oncogene 1999, 18:6853-6866. 10.1038/sj.onc.1203239 10602461
47. Bren GD Solan NJ Miyoshi H Pennington KN Pobst LJ Paya CV Transcription of the RelB gene is regulated by NF-kappa B Oncogene 2001, 20:7722-7733. 10.1038/sj.onc.1204868 11753650
48. Mueller JR Siebenlist U Lymphotoxin beta receptor induces sequential activation of distinct NF-kappa B factors via separate signaling pathways J Biol Chem 2003, 278:12006-12012. 10.1074/jbc.M210768200 12556537
49. Basak S Kim H Kearns JD Tergaonkar V O'Dea E Werner SL Benedict CA Ware CF Ghosh G Verma IM Hoffmann A A fourth IkappaB protein within the NF-kappaB signaling module Cell 2007, 128:369-381. 1831796 17254973 10.1016/j.cell.2006.12.033
50. Dejardin E The alternative NF-kappaB pathway from biochemistry to biology: Pitfalls and promises for future drug development Biochem Pharmacol 2006, 72:1161-1179. 10.1016/j.bcp.2006.08.007 16970925
51. Matsushima A Kaisho T Rennert PD Nakano H Kurosawa K Uchida D Takeda K Akira S Matsumoto M Essential role of nuclear factor (NF)-kappaB-inducing kinase and inhibitor of kappaB (IkappaB) kinase alpha in NF-kappaB activation through lymphotoxin beta receptor, but not through tumor necrosis factor receptor I J Exp Med 2001, 193:631-636. 2193391 11238593 10.1084/jem.193.5.631
52. Hehlgans T Pfeffer K The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: Players, rules and the games Immunology 2005, 115:1-20. 1782125 15819693 10.1111/ j.1365-2567.2005.02143.x
53. Gray DH Seach N Ueno T Milton MK Liston A Lew AM Goodnow CC Boyd RL Developmental kinetics, turnover, and stimulatory capacity of thymic epithelial cells Blood 2006, 108:3777-3785. 10.1182/blood-2006-02-004531 16896157
54. Rossi SW Kim MY Leibbrandt A Parnell SM Jenkinson WE Glanville SH McConnell FM Scott HS Penninger JM Jenkinson EJ Lane PJ Anderson G RANK signals from CD4+3- inducer cells regulate development of Aire-expressing epithelial cells in the thymic medulla J Exp Med 2007, 204:1267-1272. 2118623 17502664 10.1084/jem.20062497
55. Sakaguchi N Takahashi T Hata H Nomura T Tagami T Yamazaki S Sakihama T Matsutani T Negishi I Nakatsuru S Sakaguchi S Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice Nature 2003, 426:454-460. 10.1038/nature02119 14647385
56. Yoshitomi H Sakaguchi N Kobayashi K Brown GD Tagami T Sakihama T Hirota K Tanaka S Nomura T Miki I Gordon S Akira S Nakamura T Sakaguchi S A role for fungal β-glucans and their receptor Dectin-1 in the induction of autoimmune arthritis in genetically susceptible mice J Exp Med 2005, 201:949-960. 2213107 15781585 10.1084/jem.20041758
57. Karin M Lawrence T Nizet V Innate immunity gone awry: Linking microbial infections to chronic inflammation and cancer Cell 2006, 124:823-835. 10.1016/j.cell.2006.02.016 16497591
58. Harris ED Rheumatoid Arthritis Philadelphia, PA: WB Saunders 1997.
59. Feldmann M Brennan FM Maini RN Rheumatoid arthritis Cell 1996, 85:307-310. 10.1016/S0092-8674(00)81109-5 8616886
60. Firestein GS Etiology and pathogenesis of rheumatoid arthritis Textbook of Rheumatology Philadelphia, PA: WB Saunders Kelley WN, Harris ED Jr, Ruddy S, Sledge C 1997, 851-897.
61. Valero R Baron ML Guerin S Beliard S Lelouard H Kahn-Perles B Vialettes B Nguyen C Imbert J Naquet P A defective NF-kappa B/RelB pathway in autoimmuneprone New Zealand black mice is associated with inefficient expansion of thymocyte and dendritic cells J Immunol 2002, 169:185-192. 12077244
62. Mackay F Schneider P Rennert P Browning J BAFF AND APRIL: A tutorial on B cell survival Annu Rev Immunol 2003, 21:231-264. 10.1146/ annurev.immunol.21.120601.141152 12427767
63. Miller JP Stadanlick JE Cancro MP Space, selection, and surveillance: setting boundaries with BLyS J Immunol 2006, 176:6405-6410. 16709796
64. Calzado MA Bacher S Schmitz ML NF-kappaB inhibitors for the treatment of inflammatory diseases and cancer Curr Med Chem 2007, 14:367-376. 10.2174/ 092986707779941113 17305539
65. Dejardin E The alternative NF-kappaB pathway from biochemistry to biology: Pitfalls and promises for future drug development Biochem Pharmacol 2006, 72:1161-1179. 10.1016/j.bcp.2006.08.007 16970925
66. Wengner AM Hopken UE Petrow PK Hartmann S Schurigt U Brauer R Lipp M CXCR5- and CCR7-dependent lymphoid neogenesis in a murine model of chronic antigen-induced arthritis Arthritis Rheum 2007, 56:3271-3283. 10.1002/art.22939 17907173
67. Drayton DL Liao S Mounzer RH Ruddle NH Lymphoid organ development: From ontogeny to neogenesis Nat Immunol 2006, 7:344-353. 10.1038/ni1330 16550197
68. Gommerman JL Browning JL Lymphotoxin/light, lymphoid microenvironments and autoimmune disease Nat Rev Immunol 2003, 3:642-655. 10.1038/nri1151 12974479
69. Ng LG Mackay CR Mackay F The BAFF/APRIL system: Life beyond B lymphocytes Mol Immunol 2005, 42:763-772. 10.1016/j.molimm.2004.06.041 15829264
70. Ettinger R Sims GP Robbins R Withers D Fischer RT Grammer AC Kuchen S Lipsky PE IL-21 and BAFF/BLyS synergize in stimulating plasma cell differentiation from a unique population of human splenic memory B cells J Immunol 2007, 178:2872-2882. 17312131
71. Edwards JC Cambridge G B-cell targeting in rheumatoid arthritis and other autoimmune diseases Nat Rev Immunol 2006, 6:394-403. 10.1038/ nri1838 16622478
72. Stohl W Targeting B-lymphocyte stimulator (BLyS) in immune-based rheumatic diseases: A therapeutic promise waiting to be fulfilled Contemporary Targeted Therapies in Rheumatology London: Informa Smolen JS, Lipsky PE 2007, 527-542.
73. Aya K Alhawagri M Hagen-Stapleton A Kitaura H Kanagawa O Novack DV NF-(kappa)B-inducing kinase controls lymphocyte and osteoclast activities in inflammatory arthritis J Clin Invest 2005, 115:1848-1854. 1142111 15937549 10.1172/JCI23763
74. Bondeson J Foxwell B Brennan F Feldmann M Defining therapeutic targets by using adenovirus: Blocking NF-kappa B inhibits both inflammatory and destructive mechanisms in rheumatoid synovium but spares anti-inflammatory mediators Proc Natl Acad Sci USA 1999, 96:5668-5673. 21918 10318942 10.1073/pnas.96.10.5668
75. Amos N Lauder S Evans A Feldmann M Bondeson J Adenoviral gene transfer into osteoarthritis synovial cells using the endogenous inhibitor Ikappa B alpha reveals that most, but not all, inflammatory and destructive mediators are NF-kappa B dependent Rheumatology (Oxford) 2006, 45:1201-1209. 10.1093/rheumatology/kel078 16571608
76. Noss EH Brenner MB Cadherin-11 mediates synovial lining organization: A new therapeutic target in inflammatory arthritis Contemporary Targeted Therapies in Rheumatology London: Informa Smolen JS, Lipsky PE 2007, 121:131.
77. Foxwell B Browne K Bondeson J Clarke C de Martin R Brennan F Feldmann M Efficient adenoviral infection with Ikappa B alpha reveals that macrophage tumor necrosis factor alpha production in rheumatoid arthritis is NF-kappa B dependent Proc Natl Acad Sci USA 1998, 95:8211-8215. 20955 9653166 10.1073/pnas.95.14.8211
78. Bondeson J Lauder S Wainwright S Amos N Evans A Hughes C Feldmann M Caterson B Adenoviral gene transfer of the endogenous inhibitor Ikappa B alpha into human osteoarthritis synovial fibroblasts demonstrates that several matrix metalloproteinases and aggrecanases are nuclear factor-kappaB-dependent J Rheumatol 2007, 34:523-533. 17295438
79. Makarov SS NF-kappa B in rheumatoid arthritis: A pivotal regulator of inflammation, hyperplasia, and tissue destruction Arthritis Res 2001, 3:200-206. 128895 11438035 10.1186/ar300
80. Zhang HG Huang N Liu D Bilbao L Zhang X Yang P Zhou T Curiel DT Mountz JD Gene therapy that inhibits nuclear translocation of nuclear factor kappaB results in tumor necrosis factor alpha-induced apoptosis of human synovial fibroblasts Arthritis Rheum 2000, 43:1094-1105. 10.1002/ 1529-0131(200005)43:5<1094::AID-ANR20>3.0.CO;2-V 10817564
81. Miagkov AV Kovalenko DV Brown CE Didsbury JR Cogswell JP Stimpson SA Baldwin AS Makarov SS NF-kappaB activation provides the potential link between inflammation and hyperplasia in the arthritic joint Proc Natl Acad Sci USA 1998, 95:13859-13864. 24931 9811891 10.1073/pnas.95.23.13859
82. Feldmann M Andreakos E Smith C Bondeson J Yoshimura S Kiriakidis S Monaco C Gasparini C Sacre S Lundberg A Paleolog E Horwood NJ Brennan FM Foxwell BMJ Is NF-kappa B a useful therapeutic target in rheumatoid arthritis? Ann Rheum Dis 2002, 61(suppl II):iI13-ii18. 1766706 12379614
83. Drexler SK Turner JJO Foxwell BM Clinical prospects of NF-kappa B inhibitors to further targeted therapies in rheumatology Contemporary Targeted Therapies in Rheumatology London: Informa Smolen JS, Lipsky PE 2007, 581-600.
84. McInnes IB Schett G Cytokines in the pathogenesis of rheumatoid arthritis Nat Rev Immunol 2007, 7:429-442. 10.1038/nri2094 17525752
85. Toh ML Miossec P The role of T cells in rheumatoid arthritis: New subsets and new targets Curr Opin Rheumatol 2007, 19:284-288. 10.1097/ BOR.0b013e32805e87e0 17414957
86. Koenders MI Lubberts E Loo van de FA Oppers-Walgreen B Bersselaar van den L Helsen MM Kolls JK Di Padova FE Joosten LA Berg van den WB Interleukin-17 acts independently of TNF-alpha under arthritic conditions J Immunol 2006, 176:6262-6269. 16670337
87. Kageyama Y Ichikawa T Nagafusa T Torikai E Shimazu M Nagano A Etanercept reduces the serum levels of interleukin-23 and macrophage inflammatory protein-3 alpha in patients with rheumatoid arthritis Rheumatol Int 2007, 28:137-143. 10.1007/s00296-007-0388-4 17619881
88. Weaver CT Hatton RD Mangan PR Harrington LE IL-17 family cytokines and the expanding diversity of effector T cell lineages Annu Rev Immunol 2007, 25:821-852. 10.1146/annurev.immunol.25.022106.141557 17201677
89. Schnyder-Candrian S Togbe D Couillin I Mercier I Brombacher F Quesniaux V Fossiez F Ryffel B Schnyder B Interleukin-17 is a negative regulator of established allergic asthma J Exp Med 2006, 203:2715-2725. 2118159 17101734 10.1084/jem.20061401
90. Muller A Lamprecht P Interleukin-17 in chronic inflammatory and autoimmune diseases: Rheumatoid arthritis, Crohn's disease, and Wegener's granulomatosis [in German] Z Rheumatol 2008, 67:72-74. 10.1007/ s00393-007-0236-7 18004573
91. Acosta-Rodriguez EV Napolitani G Lanzavecchia A Sallusto F Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells Nat Immunol 2007, 8:942-949. 10.1038/ni1496 17676045
92. van Beelen AJ Zelinkova Z Taanman-Kueter EW Muller FJ Hommes DW Zaat SA Kapsenberg ML de Jong EC Stimulation of the intracellular bacterial sensor NOD2 programs den-dritic cells to promote interleukin-17 production in human memory T cells Immunity 2007, 27:660-669. 10.1016/ j.immuni.2007.08.013 17919942
93. Afzali B Lombardi G Lechler RI Lord GM The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease Clin Exp Immunol 2007, 148:32-46. 1868863 17328715
94. Kramer JM Gaffen SL Interleukin-17: A new paradigm in inflammation, autoimmunity, and therapy J Periodontol 2007, 78:1083-1093. 10.1902/ jop.2007.060392 17539723
95. Yu JJ Gaffen SL Interleukin-17: A novel inflammatory cytokine that bridges innate and adaptive immunity Front Biosci 2008, 13:170-177. 10.2741/2667 17981535
96. Paradowska A Masliniski W Grzybowska-Kowalczyk A Lacki J The function of interleukin 17 in the pathogenesis of rheumatoid arthritis Arch Immunol Ther Exp (Warsz) 2007, 55:329-334. 10.1007/s00005-007-0032-8 18219763
97. Stockinger B Veldhoen M Martin B Th17 T cells: Linking innate and adaptive immunity Semin Immunol 2007, 19:353-361. 10.1016/ j.smim.2007.10.008 18023589
98. Schmidt-Weber CB Akdis M Akdis CA TH17 cells in the big picture of immunology J Allergy Clin Immunol 2007, 120:247-254. 10.1016/ j.jaci.2007.06.039 17666214
99. Romagnani S Human Th17 cells Arthritis Res Ther 2008, 10:206-213. 2453756 18466633 10.1186/ar2392
100. Yamada H Nakashima Y Okazaki K Mawatari T Fukushi JI Kaibara N Hori A Iwamoto Y Yoshikai Y Th1 but not Th17 cells predominate in the joints of patients with rheumatoid arthritis Ann Rheum Dis 2007. 18063670
101. Nakae S Nambu A Sudo K Iwakura Y Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice J Immunol 2003, 171:6173-6177. 14634133
102. Lubberts E Koenders MI Oppers-Walgreen B Bersselaar van den L Coenen-de Roo CJ Joosten LA Berg van den WB Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion Arthritis Rheum 2004, 50:650-659. 10.1002/art.20001 14872510
103. Koenders MI Kolls JK Oppers-Walgreen B Bersselaar van den L Joosten LA Schurr JR Schwarzenberger P Berg van den WB Lubberts E Interleukin-17 receptor deficiency results in impaired synovial expression of interleukin-1 and matrix met-alloproteinases 3, 9, and 13 and prevents cartilage destruction during chronic reactivated streptococcal cell wall-induced arthritis Arthritis Rheum 2005, 52:3239-3247. 10.1002/ art.21342 16200598
104. Roark CL French JD Taylor MA Bendele AM Born WK O'Brien RL Exacerbation of collagen-induced arthritis by oligoclonal, IL-17-producing gamma delta T cells J Immunol 2007, 179:5576-5583. 17911645
105. Hirota K Hashimoto M Yoshitomi H Tanaka S Nomura T Yamaguchi T Iwakura Y Sakaguchi N Sakaguchi S T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritis J Exp Med 2007, 204:41-47. 2118414 17227914 10.1084/ jem.20062259
106. Abdollahi-Roodsaz S Joosten LA Koenders MI Devesa I Roelofs MF Radstake TR Heuvelmans-Jacobs M Akira S Nicklin MJ Ribeiro-Dias F Berg van den WB Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis J Clin Invest 2008, 118:205-216. 2104479 18060042 10.1172/JCI32639
107. Berg van den WB van Lent PL Joosten LA Abdollahi-Roodsaz S Koenders MI Amplifying elements of arthritis and joint destruction Ann Rheum Dis 2007, 66(suppl 3):iIi45-iii48. 10.1136/ard.2007.079830 17934095
108. Kim KW Cho ML Lee SH Oh HJ Kang CM Ju JH Min SY Cho YG Park SH Kim HY Human rheumatoid synovial fibroblasts promote osteoclastogenic activity by activating RANKL via TLR-2 and TLR-4 activation Immunol Lett 2007, 110:54-64. 10.1016/j.imlet.2007.03.004 17467812
109. Kawai T Akira S Signaling to NF-kappaB by Toll-like receptors Trends Mol Med 2007, 13:460-469. 10.1016/j.molmed.2007.09.002 18029230
110. Yago T Nanke Y Kawamoto M Furuya T Kobashigawa T Kamatani N Kotake S IL-23 induces human osteoclastogenesis via IL-17 in vitro, and anti-IL-23 antibody attenuates collagen-induced arthritis in rats Arthritis Res Ther 2007, 9:R96. 2212562 17888176 10.1186/ar2297
111. Schett G Joint remodelling in inflammatory disease Ann Rheum Dis 2007, 66(suppl 3):iIi42-iii44. 10.1136/ard.2007.078972 17934094
112. Tarner IH Muller-Ladner U Gay S Emerging targets of biologic therapies for rheumatoid arthritis Nat Clin Pract Rheumatol 2007, 3:336-345. 10.1038/ncprheum0506 17538565
113. Cho YG Cho ML Min SY Kim HY Type II collagen autoimmunity in a mouse model of human rheumatoid arthritis Autoimmun Rev 2007, 7:65-70. 10.1016/ j.autrev.2007.08.001 17967728
114. Sato K Suematsu A Okamoto K Yamaguchi A Morishita Y Kadono Y Tanaka S Kodama T Akira S Iwakura Y Cua DJ Takayanagi H Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction J Exp Med 2006, 203:2673-2682. 2118166 17088434 10.1084/ jem.20061775
115. Boyce BF Schwarz EM Xing L Osteoclast precursors: Cytokine-stimulated immunomodulators of inflammatory bone disease Curr Opin Rheumatol 2006, 18:427-432. 10.1097/01.bor.0000231913.32364.32 16763465
116. Boyce BF Xing L Biology of RANK, RANKL, and osteoprotegerin Arthritis Res Ther 2007, 9(suppl 1):S1. 1924516 17634140 10.1186/ar2165
117. Sheibanie AF Khayrullina T Safadi FF Ganea D Prostaglandin E2 exacerbates collagen-induced arthritis in mice through the inflammatory interleukin-23/interleukin-17 axis Arthritis Rheum 2007, 56:2608-2619. 10.1002/art.22794 17665454
118. Xing L Schwarz EM Boyce BF Osteoclast precursors, RANKL/RANK, and immunology Immunol Rev 2005, 208:19-29. 10.1111/j.0105-2896.2005.00336.x 16313338
119. Nakajima H Takatsu K Role of cytokines in allergic airway inflammation Int Arch Allergy Immunol 2007, 142:265-273. 10.1159/000097357 17124428
120. Linden A A role for the cytoplasmic adaptor protein Act1 in mediating IL-17 signaling Sci STKE 2007, 398:rE4. 10.1126/stke.3982007re4 17684298
121. Li X Act1 modulates autoimmunity through its dual functions in CD40L/ BAFF and IL-17 signaling Cytokine 2008, 41:105-113. 10.1016/ j.cyto.2007.09.015 18061473
122. Qian Y Liu C Hartupee J Altuntas CZ Gulen MF Jane-Wit D Xiao J Lu Y Giltiay N Liu J Kordula T Zhang QW Vallance B Swaidani S Aronica M Tuohy VK Hamilton T Li X The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease Nat Immunol 2007, 8:247-256. 10.1038/ni1439 17277779
123. Leonardi A Chariot A Claudio E Cunningham K Siebenlist U CIKS, a connection to Ikappa B kinase and stress-activated protein kinase Proc Natl Acad Sci USA 2000, 97:10494-10499. 27052 10962033 10.1073/ pnas.190245697
124. Maitra A Shen F Hanel W Mossman K Tocker J Swart D Gaffen SL Distinct functional motifs within the IL-17 receptor regulate signal transduction and target gene expression Proc Natl Acad Sci USA 2007, 104:7506-7511. 1863505 17456598 10.1073/pnas.0611589104
125. Hartupee J Liu C Novotny M Li X Hamilton T IL-17 enhances chemokine gene expression through mRNA stabilization J Immunol 2007, 179:4135-4141. 17785852
126. Matsuo S Yamazaki S Takeshige K Muta T Crucial roles of binding sites for NF-kappaB and C/EBPs in IkappaB-zeta-mediated transcriptional activation Biochem J 2007, 405:605-615. 2267307 17447895 10.1042/ BJ20061797
127. Kayagaki N Yan M Seshasayee D Wang H Lee W French DM Grewal IS Cochran AG Gordon NC Yin J Starovasnik MA Dixit VM BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-kappaB2 Immunity 2002, 17:515-524. 10.1016/ S1074-7613(02)00425-9 12387744
128. Mackay F Woodcock SA Lawton P Ambrose C Baetscher M Schneider P Tschopp J Browning JL Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations J Exp Med 1999, 190:1697-1710. 2195729 10587360 10.1084/jem.190.11.1697
129. Khare SD Sarosi I Xia XZ McCabe S Miner K Solovyev I Hawkins N Kelley M Chang D Van G Ross L Delaney J Wang L Lacey D Boyle WJ Hsu H Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice Proc Natl Acad Sci USA 2000, 97:3370-3375. 16246 10716715 10.1073/ pnas.050580697
130. Gross JA Johnston J Mudri S Enselman R Dillon SR Madden K Xu W Parrish-Novak J Foster D Lofton-Day C Moore M Littau A Grossman A Haugen H Foley K Blumberg H Harrison K Kindsvogel W Clegg CH TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease Nature 2000, 404:995-999. 10.1038/35010115 10801128
131. Makarov SS Gene therapy for rheumatoid arthritis: Preclinical studies Gene Therapy in Inflammatory Diseases Basel, Switzerland: Verlag Evans CH, Robbins PD 2000, 13-35.
132. Bacher S Schmitz ML The NF-kappaB pathway as a potential target for autoimmune disease therapy Curr Pharm Des 2004, 10:2827-2837. 10.2174/ 1381612043383584 15379671
133. Okamoto T NF-kappaB and rheumatic diseases Endocr Metab Immune Disord Drug Targets 2006, 6:359-372. 17214582